Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia

In the recent years, using genetically modified T cells has been known as a rapid developing therapeutic approach due to the heartwarming results of clinical trials with patients suffering from relapsed or refractory (R/R) hematologic malignancies such as R/R Acute Lymphoblastic Leukemia (R/R ALL)....

Descripción completa

Detalles Bibliográficos
Autores principales: Hashem Boroojerdi, Mohadese, Rahbarizadeh, Fatemeh, Safarzadeh Kozani, Pouya, Kamali, Elahe, Safarzadeh Kozani, Pooria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549730/
https://www.ncbi.nlm.nih.gov/pubmed/33047234
http://dx.doi.org/10.1007/s12032-020-01416-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549730/
https://www.ncbi.nlm.nih.gov/pubmed/33047234
http://dx.doi.org/10.1007/s12032-020-01416-3

Ejemplares similares